The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe
Open accessAbstract
BACKGROUND & AIMS Antibiotic resistance has been increasingly reported in patients with decompensated cirrhosis in single-center studies. Prospective investigations reporting broad epidemiological data are scarce. We aimed to analyze epidemiological changes in bacterial infections in patients with decompensated cirrhosis. METHODS This was a prospective evaluation of 2 series of patients hospitalized with decompensated cirrhosis. The Canonic series included 1,146 patients from Northern, Southern and Western Europe in 2011. Data on epidemiology, clinical characteristics of bacterial infections, microbiology and empirical antibiotic schedules were assessed. A second series of 883 patients from Eastern, Southern and Western Europe was investigated between 2017-2018. RESULTS A total of 455 patients developed 520 infections (39.7%) in the first series, with spontaneous bacterial peritonitis, urinary tract infections and pneumonia the most frequent infections. Nosocomial episodes predominated in this series. Nearly half of the infections were culture-positive, of which 29.2% were caused by multidrug-resistant organisms (MDROs). MDR strains were more frequently isolated in Northern and Western Europe. Extended-spectrum beta-lactamase-producing Enterobacteriaceae were the most frequent MDROs isolated in this series, although prevalence and type differed markedly among countries and centers. Antibiotic resistance was associated with poor prognosis and failure of antibiotic strategies, based on third-generation cephalosporins or quinolones. Nosocomial infection (odds ratio [OR] 2.74; p < 0.001), intensive care unit admission (OR 2.09; p = 0.02), and recent hospitalization (OR 1.93; p = 0.04) were identified as independent predictors of MDR infection. The prevalence of MDROs in the second series (392 infections/284 patients) was 23%; 38% in culture-positive infections. A mild increase in the rate of carbapenem-resistant Enterobacteriaceae was observed in this series. CONCLUSIONS MDR bacterial infections constitute a prevalent, growing and complex healthcare problem in patients with decompensated cirrhosis and acute-on-chronic liver failure across Europe, negatively impacting on prognosis. Strategies aimed at preventing the spread of antibiotic resistance in cirrhosis should be urgently evaluated. LAY SUMMARY Infections caused by bacteria resistant to the main antibiotic families are prevalent in patients with cirrhosis. This study demonstrates that this healthcare problem is increasing and extends through all European regions. Infections caused by these difficult to treat bacteria resolve less frequently and often cause the death of the patient. The type of resistant bacteria varies markedly among different hospitals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,020
Self-citationArvaniti, V., D'Amico, G., Fede, G., Manousou, P., Tsochatzis, E., Pleguezuelo, M., & Burroughs, A. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.019 · Cited by 1,167
Fernández, J., Navasa, M., Gómez, J., Colmenero, J., Vila, J., Arroyo, V., & Rodés, J. (2002) · Hepatology · doi:10.1053/jhep.2002.30082 · Cited by 954
Self-citationBacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013
Jalan, R., Fernandez, J., Wiest, R., Schnabl, B., Moreau, R., Angeli, P., Stadlbauer, V., Gustot, T., Bernardi, M., Canton, R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.024 · Cited by 906
Self-citationFernández, J., Acevedo, J., Castro, M., Garcia, O., de Lope, C. R., Roca, D., Pavesi, M., Sola, E., Moreira, L., Silva, A., et al. (2012) · Hepatology · doi:10.1002/hep.25532 · Cited by 620
Self-citationFernández, J., Acevedo, J., Wiest, R., Gustot, T., Amoros, A., Deulofeu, C., Reverter, E., Martínez, J., Saliba, F., Jalan, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314240 · Cited by 572
Self-citationBajaj, J. S., O'Leary, J. G., Reddy, K. R., Wong, F., Olson, J. C., Subramanian, R. M., Brown, G., Noble, N. A., Thacker, L. R., Kamath, P. S., et al. (2012) · Hepatology · doi:10.1002/hep.25947 · Cited by 413
New antibiotics for bad bugs: where are we?
Bassetti, M., Merelli, M., Temperoni, C., & Astilean, A. (2013) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-12-22 · Cited by 403
Impact of antimicrobial stewardship in critical care: a systematic review
Kaki, R., Elligsen, M., Walker, S., Simor, A., Palmay, L., & Daneman, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr137 · Cited by 386
Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections
Merli, M., Lucidi, C., Giannelli, V., Giusto, M., Riggio, O., Falcone, M., Ridola, L., Attili, A. F., & Venditti, M. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.06.024 · Cited by 324
Self-citationPerez, K. K., Olsen, R. J., Musick, W. L., Cernoch, P. L., Davis, J. R., Peterson, L. E., & Musser, J. M. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.05.005 · Cited by 321
Gudiol, C., Tubau, F., Calatayud, L., Garcia-Vidal, C., Cisnal, M., Sanchez-Ortega, I., Duarte, R., Calvo, M., & Carratala, J. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq494 · Cited by 246
Piano, S., Fasolato, S., Salinas, F., Romano, A., Tonon, M., Morando, F., Cavallin, M., Gola, E., Sticca, A., Loregian, A., et al. (2016) · Hepatology · doi:10.1002/hep.27941 · Cited by 243
Self-citationAntibiotic prophylaxis in cirrhosis: Good and bad
Fernández, J., Tandon, P., Mensa, J., & Garcia‐Tsao, G. (2016) · Hepatology · doi:10.1002/hep.28330 · Cited by 203
Self-citationThe challenges of multi-drug-resistance in hepatology
Fernández, J., Bert, F., & Nicolas-Chanoine, M.-H. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.006 · Cited by 187
Self-citationCheong, H. S., Kang, C., Lee, J. A., Moon, S. Y., Joung, M. K., Chung, D. R., Koh, K. C., Lee, N. Y., Song, J., & Peck, K. R. (2009) · Clinical Infectious Diseases · doi:10.1086/597585 · Cited by 178
Campillo, B., Richardet, J., Kheo, T., & Dupeyron, C. (2002) · Clinical Infectious Diseases · doi:10.1086/340617 · Cited by 177
Ariza, X., Castellote, J., Lora-Tamayo, J., Girbau, A., Salord, S., Rota, R., Ariza, J., & Xiol, X. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.010 · Cited by 161
Tandon, P., DeLisle, A., Topal, J. E., & Garcia–Tsao, G. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.08.017 · Cited by 158
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis
Bartoletti, M., Giannella, M., Caraceni, P., Domenicali, M., Ambretti, S., Tedeschi, S., Verucchi, G., Badia, L., Lewis, R. E., Bernardi, M., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.021 · Cited by 132
Self-citationUmgelter, A., Reindl, W., Miedaner, M., Schmid, R. M., & Huber, W. (2009) · Infection · doi:10.1007/s15010-008-8060-9 · Cited by 124
Merli, M., Lucidi, C., Gregorio, V. D., Falcone, M., Giannelli, V., Lattanzi, B., Giusto, M., Ceccarelli, G., Farcomeni, A., Riggio, O., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127448 · Cited by 107
Self-citationGustot, T., Felleiter, P., Pickkers, P., Sakr, Y. L., Rello, J., Velissaris, D., Pierrakos, C. N., Taccone, F. S., Ševčík, P., Moreno, C., et al. (2014) · Liver International · doi:10.1111/liv.12520 · Cited by 105
Self-citationCrum-Cianflone, N. F., Sullivan, E., & Ballon-Landa, G. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00820-15 · Cited by 103
Antibiotic resistance: a geopolitical issue
Carlet, J. M., Pulcini, C., & Piddock, L. J. V. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12767 · Cited by 102
Naas, T., Cuzon, G., Truong, H. T., Bernabeu, S., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01298-09 · Cited by 100
Bartoletti, M., Giannella, M., Lewis, R. E., Caraceni, P., Tedeschi, S., Paul, M., Schramm, C., Bruns, T., Merli, M., Cobos-Trigueros, N., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.08.001 · Cited by 97
Self-citationSong, K., Jeon, J. H., Park, W. B., Park, S., Kim, H. B., Oh, M., Lee, H.-S., Kim, N. J., & Choe, K. W. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-41 · Cited by 87
Mancini, N., Infurnari, L., Ghidoli, N., Valzano, G., Clementi, N., Burioni, R., & Clementi, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00142-14 · Cited by 82
Merli, M., Lucidi, C., Gregorio, V. D., Lattanzi, B., Giannelli, V., Giusto, M., Farcomeni, A., Ceccarelli, G., Falcone, M., Riggio, O., et al. (2015) · Hepatology · doi:10.1002/hep.28332 · Cited by 80
Self-citationNahon, P., Lescat, M., Layese, R., Bourcier, V., Talmat, N., Allam, S., Marcellin, P., Guyader, D., Pol, S., Larrey, D. G., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310275 · Cited by 79
Salerno, F., Borzio, M., Pedicino, C., Simonetti, R. G., Rossini, A., Boccia, S., Cacciola, I., Burroughs, A. K., Manini, M. A., Mura, V. L., et al. (2016) · Liver International · doi:10.1111/liv.13195 · Cited by 79
Self-citationAlexopoulou, A. A., Vasilieva, L., Agiasotelli, D., Siranidi, K., Pouriki, S., Tsiriga, A., Toutouza, M. G., & Dourakis, S. P. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i15.4049 · Cited by 68
Bacterial epidemiology and antimicrobial resistance in ascitic fluid: A 2-year retrospective study
Piroth, L., Péchinot, A., Minello, A., Jaulhac, B., Patry, I., Hadou, T., Hansmann, Y., Rabaud, C., Chavanet, P., & Neuwirth, C. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903244535 · Cited by 53
Bert, F., Larroque, B., Dondero, F., Durand, F., Paugam‐Burtz, C., Belghiti, J., Moreau, R., & Nicolas-Chanoine, M.-H. (2013) · Transplant Infectious Disease · doi:10.1111/tid.12169 · Cited by 47
Self-citationSargenti, K., Prytz, H., Strand, A., Nilsson, E., & Kalaitzakis, E. (2014) · Liver International · doi:10.1111/liv.12625 · Cited by 45
Chaulk, J., Carbonneau, M., Qamar, H., Keough, A., Chang, H.-J., Ma, M. M., Kumar, D., & Tandon, P. (2014) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2014/429536 · Cited by 42
Novovic, S., Semb, S., Olsen, H., Moser, C. E., Knudsen, J. D., & Homann, C. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.645502 · Cited by 42
Nazer, L. H., Kharabsheh, A., Rimawi, D., Mubarak, S., & Hawari, F. I. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0032 · Cited by 32
Baştuğ, A., Kayaaslan, B., Kazancıoğlu, S., But, A., Aslaner, H., Akıncı, E., Yetkin, M. A., Kanyılmaz, D., Eren, S., & Bodur, H. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6805 · Cited by 12
Cited by
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Biggins, S. W., Angeli, P., Garcia‐Tsao, G., Ginès, P., Ling, S. C., Nadim, M. K., Wong, F., & Kim, W. R. (2021) · Hepatology · doi:10.1002/hep.31884 · Cited by 846
Self-citationGuidelines on the management of ascites in cirrhosis
Aithal, G. P., Palaniyappan, N., China, L., Härmälä, S., Macken, L., Ryan, J. M., Wilkes, E. A., Moore, K., Leithead, J. A., Hayes, P. C., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321790 · Cited by 680
EASL Clinical Practice Guidelines on acute-on-chronic liver failure
Moreau, R., Tonon, M., Krag, A., Angeli, P., Berenguer, M., Berzigotti, A., Fernandez, J., Francoz, C., Gustot, T., Jalan, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.021 · Cited by 375
Self-citationTrebicka, J., Fernandez, J., Papp, M., Caraceni, P., Laleman, W., Gambino, C., Giovo, I., Uschner, F. E., Jansen, C., Jimenez, C., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.019 · Cited by 304
Self-citation
Metadata
- Authors
- Fernández, J., Prado, V., Trebicka, J., Amoros, A., Gustot, T., Wiest, R., Deulofeu, C., Garcia, E., Acevedo, J., Fuhrmann, V., Durand, F., Sánchez, C., Papp, M., Caraceni, P., Vargas, V., Bañares, R., Piano, S., Janicko, M., Albillos, A., Alessandria, C., Soriano, G., Welzel, T. M., Laleman, W., Gerbes, A., De Gottardi, A., Merli, M., Coenraad, M., Saliba, F., Pavesi, M., Jalan, R., Ginès, P., Angeli, P., & Arroyo, V.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 70
- Issue
- 3
- Pages
- 398-411
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2899103797
- Cited by
- 374
- References
- 44
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.